|
2014
|
Invention
|
Aqueous suspensions of tmc278.
This invention concerns pharmaceutical compositions for administr... |
|
2012
|
Invention
|
Mutational profile in hiv-1 gag cleavage site correlated with phenotypic drug resistance. The inv... |
|
2010
|
Invention
|
Bis-benzimidazole derivatives. Inhibitors of HCV replication of formula (I) including stereochemi... |
|
2009
|
Invention
|
Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors. The present invention conc... |
|
|
Invention
|
Powders for reconstitution.
This invention relates to drinkable formulations prepared from powde... |
|
|
Invention
|
Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors. The present inventio... |
|
|
Invention
|
Method for identifying inhibitors against viruses that use a class i fusion protein. The inventio... |
|
2008
|
Invention
|
Method for determining one of the two human immunodeficiency virus (hiv) integrase enzymatic acti... |
|
|
Invention
|
Mutational profiles in hiv-1 protease correlated with phenotypic drug resistance. The present inv... |
|
|
Invention
|
Native gp41 assay.
The present invention concerns a method for identifying compounds that decrea... |
|
|
Invention
|
Relating to anti-hiv tablet formulations.
An anti-HIV tablet formulation comprising a core conta... |
|
|
Invention
|
Improvements relating to anti-hiv tablet formulations. An anti-HIV tablet formulation comprising ... |
|
|
Invention
|
Native gp41 assay. The present invention concerns a method for identifying compounds that decreas... |
|
|
Invention
|
Combination formulations.
This invention relates to solid oral dosage forms of the HIV inhibitor... |
|
|
Invention
|
Combination formulations. This invention relates to solid oral dosage forms of the HIV inhibitors... |
|
|
Invention
|
Mutational profile in hiv-1 gag cleavage site correlated with phenotypic drug resistance.
The in... |
|
|
Invention
|
New mutational profile in hiv-1 gag cleavage site correlated with phenotypic drug resistance. The... |
|
|
Invention
|
Methods for the preparation of n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfo... |
|
|
Invention
|
Powders for reconstitution. This invention relates to powders for reconstitution comprising the N... |
|
|
Invention
|
6-hydroxy-dibenzodiazepinones useful as hepatitis c virus inhibitors. Inhibitors of HCV replicati... |
|
|
Invention
|
1,1-dioxo-1-thia-5,10-diazadibenzocycloheptenes useful as hepatitis c virus inhibitors. Inhibitor... |
|
|
Invention
|
Dibenzodiazepinones useful as hepatitis c virus inhibitors. Inhibitors of HCV replication of form... |
|
|
Invention
|
10-sulfonyl-dibenzodiazepinones useful as hepatitis c virus inhibitors. Inhibitors of HCV replica... |
|
|
Invention
|
Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replicati... |
|
|
Invention
|
Hcv inhibiting macrocyclic phenylcarbamates. Compounds of the Formula (I) including a stereoisome... |
|
|
Invention
|
Pyrimidine substituted macrocyclic hcv inhibitors. Compounds of the Formula (I) including a stere... |
|
|
Invention
|
Hcv inhibiting macrocyclic phosphonates and amidophosphates. Inhibitors of HCV replication of For... |
|
|
Invention
|
Polymorphic forms of a macrocyclic inhibitor of hcv. Provided are crystalline forms of the compou... |
|
|
Invention
|
Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv. The present in... |
|
2007
|
Invention
|
Hiv inhibiting 6-substituted pyrimidines. HIV replication inhibitors of formula (I). R1 is hydrog... |
|
|
Invention
|
Hiv inhibiting 5,6-substituted pyrimidines. R1 is hydrogen; aryl; formyl; C1_6alkylcarbonyl; C1_6... |
|
|
Invention
|
Crystal structures of hiv-1 protease inhibitors bound to hiv-1 protease.
Described herein are me... |
|
|
Invention
|
Crystal structures of hiv-1 protease inhibitors bound to hiv-1 protease. Described herein are met... |
|
|
Invention
|
A homogeneous time resolved fluorescence based test system for paramyxoviridae. The present inven... |
|
|
Invention
|
Quinolinone derivatives.
HIV inhibitory compounds of formula (I) including the stereoisomeric fo... |
|
|
Invention
|
Process for preparing spray dried formulation of tmc125.
This invention relates to a process for... |
|
|
Invention
|
Methods and means for assessing hiv gag/protease inhibitor therapy.
The present invention relate... |
|
|
Invention
|
Homogeneous time resolved fluorescence based test system.
The present invention concerns a fluor... |
|
|
Invention
|
Hiv inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones. HIV inhibitory compounds of formula:
p... |
|
|
Invention
|
Methods of treating mutated hiv.
Nucleotide-competing reverse transcriptase inhibitors (NcRTI) b... |
|
2006
|
Invention
|
Fused bicyclic inhibitors of hcv. Substituted fused bicyclic pyrimidine compounds having an amide... |
|
|
Invention
|
Screening method for hiv rt inhibitors.
The present invention is directed to methods for identif... |
|
|
Invention
|
Hiv inhibiting 2-(4-cyanophenylamino) pyrimidine derivatives.
HIV replication inhibitors of form... |
|
|
Invention
|
1,5,6,-substituted-2-oxo-3-cyano-1,6a-diaza-tetrahydro-fluoranthenes as anti-inflective agents. H... |
